Anti-p38 (phospho Y182 + T180) antibody (ab4822)
- Product nameAnti-p38 (phospho Y182 + T180) antibodySee all p38 primary antibodies ...
- DescriptionRabbit polyclonal to p38 (phospho Y182 + T180)
- SpecificityReacts with p38 alpha, beta and gamma.
- Tested applicationsWB more details
- Species reactivityReacts with: Mouse, Rat, Dog, Human, Carp, Monkey
Synthetic peptide (Human) derived from the region of human p38 that contains threonine 180 and tyrosine 182. This region is conserved among many species including human, rat, mouse, dog, and carp.
- Positive controlHEK 293 cells +/- UV irradiation treatment and PC12 cells +/- Sorbitol.
- Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
- Storage bufferPreservative: 0.05% Sodium Azide
Constituents: 50% Glycerol, PBS, 1mg/ml BSA (IgG, protease free). pH 7.3
- Concentration information loading...
- PurityImmunogen affinity purified
- Purification notesPurified from rabbit serum by sequential epitope-specific chromatography. The antibody has been negatively preadsorbed using i) non-phosphopeptide corresponding to the site of phosphorylation to remove antibody that is reactive with non-phosphorylated p38, and ii) a JNK-derived peptide that is phosphorylated at threonine 183 and tyrosine 185. The final product is generated by affinity chromatography using a p38-derived peptide that is phosphorylated at threonine 180 and tyrosine 182.
- Clonality Polyclonal
- Research Areas
Our Abpromise guarantee covers the use of ab4822 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Not tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
- FunctionResponds to activation by environmental stress, pro-inflammatory cytokines and lipopolysaccharide (LPS) by phosphorylating a number of transcription factors, such as ELK1 and ATF2 and several downstream kinases, such as MAPKAPK2 and MAPKAPK5. Plays a critical role in the production of some cytokines, for example IL-6. May play a role in stabilization of EPO mRNA during hypoxic stress. Isoform Mxi2 activation is stimulated by mitogens and oxidative stress and only poorly phosphorylates ELK1 and ATF2. Isoform Exip may play a role in the early onset of apoptosis.
- Tissue specificityBrain, heart, placenta, pancreas and skeletal muscle. Expressed to a lesser extent in lung, liver and kidney.
- Sequence similaritiesBelongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. MAP kinase subfamily.
Contains 1 protein kinase domain.
- DomainThe TXY motif contains the threonine and tyrosine residues whose phosphorylation activates the MAP kinases.
modificationsDually phosphorylated on Thr-180 and Tyr-182, which activates the enzyme.
Phosphorylated upon DNA damage, probably by ATM or ATR.
- Cellular localizationCytoplasm. Nucleus.
- Entrez Gene: 403856 Dog
- Entrez Gene: 1432 Human
- Entrez Gene: 26416 Mouse
- Entrez Gene: 81649 Rat
- GenBank: NM_001315 Human
- GenBank: NM_139012 Human
- GenBank: NM_011951 Mouse
- GenBank: NM_031020 Rat
- Omim: 600289 Human
- SwissProt: O02812 Dog
- SwissProt: Q16539 Human
- SwissProt: Q5U421 Mouse
- SwissProt: P47811 Mouse
- SwissProt: Q56A33 Rat
- SwissProt: P70618 Rat
- Unigene: 485233 Human
- Unigene: 311337 Mouse
- Unigene: 88085 Rat
- CSAID Binding Protein 1 antibodyCSAID binding protein antibodyCSAID-binding protein antibody
- Csaids binding protein antibodyCSBP 1 antibodyCSBP 2 antibodyCSBP antibodyCSBP1 antibodyCSBP2 antibodyCSPB 1 antibodyCSPB1 antibodyCytokine suppressive anti inflammatory drug binding protein antibodyCytokine suppressive anti-inflammatory drug-binding protein antibodyEXIP antibodyMAP kinase 14 antibodyMAP kinase MXI2 antibodyMAP kinase p38 alpha antibodyMAPK 14 antibodyMAPK14 antibodyMAX interacting protein 2 antibodyMAX-interacting protein 2 antibodyMitogen Activated Protein Kinase 14 antibodyMitogen activated protein kinase p38 alpha antibodyMitogen-activated protein kinase 14 antibodyMitogen-activated protein kinase p38 alpha antibodyMK14_HUMAN antibodyMxi 2 antibodyMxi2 antibodyp38 ALPHA antibodyp38 antibodyp38 MAP kinase antibodyp38 MAPK antibodyp38 mitogen activated protein kinase antibodyp38ALPHA antibodyp38alpha Exip antibodyPRKM14 antibodyPRKM15 antibodyRK antibodySAPK 2A antibodySAPK2A antibodyStress Activated Protein Kinase 2A antibody
Anti-p38 (phospho Y182 + T180) antibody images
Predicted band size : 38 kDa
Peptide Competition: Extracts prepared from HEK 293 cells treated with UV irradiation were resolved on a 10% Tris-glycine gel and transferred to nitrocellulose. Membranes were blocked with a 5% BSA-TBST buffer overnight at 4oC, then were incubated with 0.50 µg/mL ab4822 for two hours at room temperature in a 3% BSA-TBST buffer, following its prior incubation with: the peptide immunogen (1), a generic phosphothreonine containing peptide (2), a generic phosphotyrosine-containing peptide (3), the non-phosphorylated peptide corresponding to the phosphopeptide (4), no peptide (5), the phosphorylated peptide derived from the corresponding region of JNK 1 & 2 (6), and, the phosphorylated peptide derived from the corresponding region of ERK 1 & 2 (7). After washing, membranes were incubated with goat F(ab')2 antirabbit IgG alkaline phosphatase and the signal was detected using the Tropix WesternStar method. The data show that only the phosphopeptide corresponding to this site blocks the antibody signal, demonstrating the specificity of ab4822 for the dually phosphorylated form of this protein.
References for Anti-p38 (phospho Y182 + T180) antibody (ab4822)
This product has been referenced in:
- Gardner A et al. The critical role of TAK1 in accentuated epithelial to mesenchymal transition in obliterative bronchiolitis after lung transplantation. Am J Pathol 180:2293-308 (2012). Read more (PubMed: 22525462) »
- Riesenhuber A et al. PERITONEAL DIALYSIS FLUID INDUCES p38-DEPENDENT INFLAMMATION IN HUMAN MESOTHELIAL CELLS. Perit Dial Int 31:332-9 (2011). WB . Read more (PubMed: 21193553) »